Are peptides legal in South Carolina?

Can a South Carolina resident get peptides by telehealth?

Section 40-47-37 of the South Carolina Code sets the rules for physicians practicing solely by telemedicine. The physician must hold a South Carolina medical license, meet the in-person standard of care, verify the patient's identity and location, and provide an appropriate evaluation before treating, which need not be in person if the physician can accurately diagnose and treat through telehealth. At each encounter the prescribing physician must obtain the threshold information needed for an accurate diagnosis in a medical history interview that the prescriber conducts, and a physician may not establish a relationship by telemedicine for prescribing when an in-person physical examination is necessary. Schedule II and III narcotic prescriptions are barred by telemedicine outside narrow exceptions; GLP-1 medicines and the peptides in this database are not scheduled. Because the statute requires a medical history interview conducted by the prescriber, a questionnaire-only asynchronous model does not clearly satisfy it, so this record marks asynchronous prescribing as unresolved. [2] [3]

How does the South Carolina pharmacy board treat compounding?

The Board of Pharmacy regulates pharmacies under the South Carolina Pharmacy Practice Act (title 40, chapter 43). Section 40-43-83 requires a permit for in-state facilities and for each permittee outside South Carolina that ships, mails, or delivers prescription drugs into the state, and allows the Board to refuse a permit that is not in the public interest. Section 40-43-86 sets facility and practice requirements, including compounding; subsection (CC)(2) bars pharmacists from offering compounded medications to other pharmacies for resale. The Board's non-resident pharmacy permit application states that South Carolina has no separate sterile or non-sterile compounding permit, but any applicant that compounds must submit its compounding documentation even if it does not plan to ship compounds into the state: for non-sterile work, 6 hours of initial and 4 hours of annual compounding education for pharmacists and technicians, a diagram and photographs of the compounding area, and temperature, humidity, and cleaning logs; for sterile work, compounding training records, a diagram and photographs of the sterile area, a month of pressure differential, temperature, humidity, and cleaning logs, and the last certification of hoods and clean areas. The Board's permit page adds that under Regulation 99-43(G)(3)(b) the pharmacist-in-charge or permit holder must appear before the Non-Resident Application Review Committee in lieu of an in-person inspection. South Carolina has not adopted a separate state list of compoundable bulk substances, so eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [4] [5] [6] [7] [8] [9]

Can you get compounded GLP-1s in South Carolina?

Telehealth GLP-1 patients should confirm that the prescriber holds a South Carolina license and that any mail order pharmacy holds a South Carolina nonresident permit under section 40-43-83. [3] [5] [12]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in South Carolina?

Find a provider in South Carolina

• Compounding pharmacies in South Carolina
• Clinics in South Carolina
• Telehealth providers in South Carolina

Is it legal to buy research peptides in South Carolina?

The South Carolina Pharmacy Practice Act limits dispensing of prescription drugs to permitted pharmacies and licensed practitioners, so an online seller shipping "research use only" injectable peptides to South Carolina consumers is not operating as a pharmacy under chapter 43. The South Carolina Board of Medical Examiners has also issued a notice that a physician may not compound, administer, prescribe, or dispense research-grade or FDA-ineligible peptides, may not delegate those acts to APRNs or PAs, and cannot rely on a patient consent form. The notice states that facilities inside or outside South Carolina may not sell or dispense drugs without a Board of Pharmacy license (S.C. Code 40-43-83 and 40-43-89), that physicians, APRNs, PAs, and pharmacists must buy all prescription products and compounding ingredients from Board of Pharmacy permitted entities, and that buying from an unpermitted source can be misconduct under S.C. Code 40-47-110(B). [4] [13] [14]

Peptide-specific notes for South Carolina

No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.

Frequently asked questions

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.